LIBOR Q1 milestones update

If you cannot see the graphic or access the links within this message please go to the source

LIBOR Q1 Milestones Update
With the path now set for LIBOR ending, what milestones in the transition should the market be focusing on?

The end of Q1 2021 will see the end of £ LIBOR loans and linear derivatives.

If you want to better understand the path through the final chapter of LIBOR, join the NatWest team as they talk through what lies ahead, how it will work and what you should be considering.

Phil Lloyd and Jamie Thrower – who both have active roles in the £ Risk Free Rate working groups – along with Dave Halstead and Luke Hasham-Smith will all share their thoughts and insights about the months ahead.

We are hosting this webinar on Zoom so make sure to register in advance using the link on the right and add the details to your diary - please note, you don't need a Zoom account or app to take part.

The NatWest Team

Event Details

Date
Tuesday 30 March 2021

Timings (in GMT)
16:00 - Presentations
16:30 - Q&A
16:40 - Close

A recording of this webinar is available from this link
Click here

Joining the Zoom webinar
To join the webinar, refer to the joining details contained within the automated registration email received directly from Zoom when you registered

To opt out of any future communications about this event, please reply to the sender of this email. You can also unsubscribe from marketing emails at any time by clicking here. Please note that opting-out of marketing communications does not affect your receipt of business communications that are important to your interaction with NatWest Markets, such as support/service communications, event registration updates or account management communications.

This event is based wholly on material which is available for access via our Agile Markets Sales & Strategy portal to any EU investment firm and is thereby an acceptable minor non-monetary benefit and not an inducement under MiFID II rules. This event therefore also qualifies as an acceptable minor non-monetary benefit and not an inducement.

Authorised in the UK by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority.